Biomarkers in Mild Stages of Alzheimer’s disease: Utility in clinical practice and their relation with nutritional and lifestyle factors

Background: The use of biomarkers in basic and clinical research as well as in clinical practice has become so common that their presence as primary endpoints in clinical trials is now accepted. A biomarker refers to a broad subcategory of medical signs. The aims of this article are to consider the of use biomarkers in Mild stages of Alzheimer’s disease (AD) in research and clinical settings, in addition to defining their utility in clinical practice relating this with nutritional and lifestyle factors as possible treatment. Methods: We searched MEDLINE, PubMed, and AgeLine databases using different keywords. Conclusions: A summary of the utility of biomarkers in AD and nutritional and lifestyle factors used as treatment in mild stages are described.

Palabras clave: Alzheimer'S Disease , Dementia , Clinical Practice , Nutritional , Biomarkers , Utility

Ver el registro completo

Archivos asociados

Tamaño: 427.1Kb

Formato: PDF

Descargar

Licencia

Excepto donde se diga explícitamente, este item se publica bajo la siguiente descripción: Creative Commons Attribution-NonCommercial-ShareAlike 2.5 Unported (CC BY-NC-SA 2.5)

Identificadores

URI: http://hdl.handle.net/11336/40195

URL: http://ffhdj.com/index.php/ffhd/article/view/299

Colecciones

Articulos(CEMIC-CONICET)
Articulos de CENTRO DE EDUCACION MEDICA E INVESTIGACIONES CLINICAS "NORBERTO QUIRNO"

Citación

Dillon, Carol; Pérez Leguizamon, Patricio; Heisecke Peralta, Silvina Lidia; Castro, Diego M.; López Camelo, Jorge Santiago; et al.; Biomarkers in Mild Stages of Alzheimer’s disease: Utility in clinical practice and their relation with nutritional and lifestyle factors; Functional Food Institute; Functional Foods in Health and Disease; 6; 10; 10-2016; 627-649